Tigulixostat (IBI128) vs Febuxostat in Gout
Clinical trial NCT07414394 · RECRUITING
Trial details
- NCT number
- NCT07414394
- Sponsor
- Innovent Biologics Technology Limited (Shanghai R&D Center)
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-17
- Primary completion
- 2027-04-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.